Central retinal disease in the form of age-related macular degeneration is now the leading cause of vision loss in persons over the age of 65 in industrialized nations.
My lab's edging fees are nominal (Zyl - no charge, metal under $3) and a large percentage of our SV lenses are FFSV. Edger doesn't make financial sense for us.
I am ignorant, yes. But when you factor in the cost of the planning, equipment, square footage, labor, maintenance, and COGS, exactly how many does one need to break even, let alone make a decent...
Whatever the percentage is, it should be higher. In-office edging is a pure profit generator, particularly if you promote some self-pay stock SV packages.